Abrogation of STAT3 DNA binding in both human and canine OSA cell lines after treatment with both inhibitors, as shown by EMSA, delineates the mechanism of loss of downstream target mRNA and protein expression. This evidence concerns the gene STAT3 and obstructive sleep apnea syndrome.